2020 Hematology andMedical Oncology Board Review

CONTEMPORARY PRACTICE

MSK CME ONLINE

INCLUDES:

Online Course Syllabus

A Maximum of 32.25 AMA PRA Category 1 Credits™ and 32.5 ABIM MOC Points

Online Format - Watch at Your Own Pace

OVERVIEW

The 2020 Memorial Sloan Kettering Hematology and Medical Oncology Board Review online course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology.

Registration for this online CME includes:

• Access to an online course syllabus (with downloadable pdf files).• A maximum of 32.25 AMA PRA Category 1 Credits™ and

32.5 ABIM MOC points.• Online format - login and watch at your own pace on virtually any

reliable internet-connected device (no downloading necessary).

David H. Ilson, MD, PhDAttending Physician, Gastrointestinal Oncology ServiceDivision of Solid Tumor OncologyDepartment of MedicineMember, Memorial Sloan Kettering Cancer CenterProfessor of Medicine, Weill Cornell Medical College

Paul A. Hamlin, MDMedical Director, David H. Koch Center for Cancer CareAssociate Attending, Lymphoma Service Division of Hematologic Malignancies Department of MedicineAssociate Professor of Medicine, Weill Cornell Medical College

Memorial Sloan Kettering Course Directors

Target Audience

This course is designed for medical oncology professionals, including physicians, nurses, pharmacists, fellows and residents.

Learning Objectives

In this CME course, attendees will:

• Learn state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers

• Learn state-of-the-science in diagnosis, staging, and therapeutic management of hematologic cancers

• Understand recent treatment advances in solid tumor and hematologic oncology and their impact on modern clinical practice

Memorial Sloan Kettering Course Faculty

Ghassan K. Abou-Alfa, MD, MBAAttending Physician Gastrointestinal Oncology Service

Carol Aghajanian, MDAttending Physician, ChiefGynecologic Medical Oncology Service

Dean F. Bajorin, MD, FACPAttending PhysicianGenitourinary Oncology ServiceFrederick R. Adler Senior Faculty Chair

Renier J. Brentjens, MD, PhDDirector, Cellular Therapeutics CenterAttending PhysicianLeukemia Service

Andrea Cercek, MDAssistant Attending PhysicianGastrointestinal Oncology Service

Paul B. Chapman, MDAttending PhysicianMelanoma and Immunotherapeutics service

Hiram S. Cody III, MD, FACSAttending SurgeonBreast ServiceProfessor of Surgery, Weill Cornell Medical College

Chau T. Dang, MDRegional Care Network Medical Site Director, MSK WestchesterAssociate Attending Physician Breast Medicine Service

Mark A. Dickson, MDAssociate Attending PhysicianSarcoma Medical Oncology Service

Darren R. Feldman, MDChair, Quality AssuranceAssistant Attending PhysicianGenitourinary Oncology ServiceAssistant Professor of Medicine, Weill Cornell Medical College

Devika Gajria, MDAssistant Attending Physician Breast Medicine Service

Mrinal M. Gounder, MDAssistant Attending PhysicianSarcoma Medical Oncology ServiceEarly Drug Development Service

Rachel N. Grisham, MD Associate Attending PhysicianGynecologic Medical Oncology Service

Christian Grommes, MDAssistant Attending PhysicianBrain Tumor Service

Komal Jhaveri, MD, FACPAssistant Attending Physician Breast Medicine Service and Early Drug Development Service

Philip Kantoff, MDChairman, Department of MedicineGeorge J. Bosl ChairProfessor of Medicine, Weill Cornell Medical College

W. Victoria Lai, MDAssistant AttendingThoracic Oncology Service

C. Ola Landgren, MD, PhDChief, Myeloma Service

Simon Mantha, MD, MPHAssociate Attending Physician Hematology Service

Anthony Mato, MDDirector, CLL ProgramAssociate Attending PhysicianLeukemia Service

Michael J. Mauro, MDAttending PhysicianLeukemia Service

Beryl McCormick, MD, FACRChief, External Beam Radiotherapy ServiceProfessor of Radiation Oncology, Weill Cornell Medical College

Jodi Mones, MDAssociate AttendingHematology Service

Alison J. Moskowitz, MDClinical Director, Lymphoma Inpatient Unit Assistant AttendingLymphoma Service

Robert J. Motzer, MDAttending PhysicianGenitourinary Oncology ServiceJack and Dorothy Byrne Chair in Clinical Oncology

Eileen M. O’Reilly, MDAssociate Director, David M. Rubenstein Center for Pancreatic CancerAttending Physician, MemberGastrointestinal Oncology ServiceWinthrop Rockefeller Chair in Medical OncologyProfessor of Medicine, Weill Cornell Medical College

David G. Pfister, MDAttending Physician, ChiefHead and Neck Oncology ServiceAssociate Deputy Physician-in-Chief, Strategic Partnerships

Gregory J. Riely, MD, PhDVice Chair, Clinical ResearchAssociate Attending PhysicianThoracic Oncology Service

Leonard B. Saltz, MDExecutive Director for Clinical Value and SustainabilityAttending PhysicianGastrointestinal Oncology ServiceProfessor of Medicine, Weill Cornell Medical College

Craig S. Sauter, MDAssistant AttendingBone Marrow Transplant Service

Neil H. Segal, MD, PhDAssociate AttendingGastrointestinal Oncology Service

Susan K. Seo, MDDirector, Antibiotic Management ProgramAttending PhysicianInfectious Disease service

Gerald A. Soff, MDChief, Hematology Service

Zsofia K. Stadler, MDClinical Director, Clinical Genetics ServiceAttending PhysicianClinical Genetics and Gastrointestinal Oncology Services

Martin S. Tallman, MDChief, Leukemia Service

Anna M. Varghese, MDAssistant Attending PhysicianGastrointestinal Oncology Service

Marjorie G. Zauderer, MDCo-Director MSK Mesothelioma ProgramAssistant Attending PhysicianThoracic Oncology Service

Andrew D. Zelenetz, MD, PhDMedical Director, Quality InformaticsAttending PhysicianLymphoma Service

60 min. Department of Medicine Grand Rounds

Novel Approaches and New Advances in Immunotherapy Treatments in Solid Tumors

Neil H. Segal, MD, PhD

Solid Tumor Session60 min. Colon Cancer Leonard B. Saltz, MD

45 min. Melanoma Paul B. Chapman, MD

45 min. Prostate Cancer Philip Kantoff, MD

45 min. Kidney Cancer Robert J. Motzer, MD

15 min. Mesothelioma Marjorie G. Zauderer, MD

45 min. Urothelial Cancer Dean F. Bajorin, MD, FACP

45 min. Testis Cancer Darren R. Feldman, MD

45 min. Uterine/Cervix/Other GYN Cancers Carol Aghajanian, MD

45 min. Ovarian Cancer Rachel N. Grisham, MD

30 min. Breast Cancer/Surgery Hiram S. Cody III, MD, FACS

30 min. Breast Cancer/Radiation Therapy Beryl McCormick, MD, FACR

45 min. Esophageal and Gastric Cancer David H. Ilson, MD, PhD

Solid Tumor Session cont. 30 min. Small Cell Lung Cancer W. Victoria Lai, MD

30 min. Breast Cancer/Hormonal Therapy Devika Gajria, MD

60 min. Breast Cancer/Advanced Disease Komal Jhaveri, MD, FACP

60 min. Breast Cancer/Adjuvant Therapy Chau T. Dang, MD

30 min. Carcinoma of Unknown Primary Anna M. Varghese, MD

45 min. Hepatocellular Cancer and Cholangiocarcinoma

Ghassan K. Abou-Alfa, MD, MBA

45 min. Pancreatic and Neuroendocrine Cancer Eileen M. O’Reilly, MD

45 min. Non Small Cell Lung Cancer Gregory J. Riely, MD, PhD

60 min. Head and Neck, Thyroid, Non Melanoma Skin Cancer

David G. Pfister, MD

30 min. Anal/Rectal Cancer Andrea Cercek, MD

30 min. Genetics Zsofia K. Stadler, MD

30 min. Sarcoma Mark A. Dickson, MD

30 min. Infectious Disease Susan Seo, MD

DAY I

DAY II

SCHEDULE

Benign Hematologic Disorders60 min. Thrombocytopenia, ITP and Beyond Gerald Soff, MD

60 min. The Role of the New Direct Oral Anticoagulants in Practice

Simon Mantha, MD, MPH

60 min. Approach to The Bleeding Patient Gerald Soff, MD

60 min. Sickle Cell Disease, Thalassemia Jodi Mones, MD

DAY III

30 min. CNS Tumors Christian Grommes, MD

Pharmacology45 min. Pharmacology I Mrinal M. Gounder, MD

65 min. Pharmacology II Mrinal M. Gounder, MD

Hematologic Oncology30 min. CART cells Renier J. Brentjens, MD, PhD

30 min. Low Grade NHL Andrew D. Zelenetz, MD, PhD

30 min. CLL/SLL Anthony Mato, MD

60 min. DLBCL/MCL/BL Paul Hamlin, MD

60 min. HL/T Cell Alison Moskowitz, MD

60 min. Auto/Allo Craig Sauter, MD

60 min. AML/ALL Martin S. Tallman, MD

60 min. MDS/MPN Michael J. Mauro, MD

60 min. Myeloma/Amyloid C. Ola Landgren, MD, PhD

DAY IV

SCHEDULE

This is best oncology/hematology review.

I thought this program was top-notch.. it covered the field very comprehensively and lectures were overall top rate.

Excellent program with great online content.

2019-2020 ATTENDEE REVIEWS

ACCREDITATION

Memorial Sloan Kettering Cancer Center is accredited by the AccreditationCouncil for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation StatementMemorial Sloan Kettering Cancer Center designates this live activity for a maximum of 32.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition StatementSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 32.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Faculty DisclosureIt is the policy of MSK to make every effort to insure balance, independence,objectivity, and scientific rigor in all continuing medical education activities which it provides as an ACCME accredited provider. In accordance with ACCME guidelines and standards, all faculty participating in an activity provided by MSK are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services which are discussed by the faculty members in an educational presentation. As required by the ACCME, when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, MSK requires the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigational.

Register Online:mskcc.org/hemoncboardreview2020

Registration Fee: $1,500(includes access to an online course syllabus)

Discounted rate available for MSK Alumni,MSK Cancer Alliance and Cancer Care Partners.

MSK employee registration is complimentary.

Registrations are non-refundable.

All course content and resources (videos, ABIM MOC post-test, evaluation and certificates) are available on the MSK CME Portal: mskcc.org/cme Please note that the videos and the ABIM MOC post-test will only be available through November 1, 2020. If you have any questions or concerns, email cme@mskcc.org

Accessing the VideosYou have the ability to watch the videos at your own pace. Please note, however, that if you pause a video before it is complete, we encourage you to make a note of the time in which you have paused. When you log out of the Portal and enter again to resume, the place in which you previously stopped will not automatically save and you will need to fast forward to that section again. You can fast forward/rewind at any time.

• Sign in to the MSK CME Portal, mskcc.org/cme, using the username and passwordentered at registration. MSK employees must use their SSO credentials to sign in.

• Once you are successfully logged into the MSK CME Portal, all resources will be availableunder My CME in the upper right corner (upper left corner of a smart phone or tablet).

• The videos are available under ‘Tests’. There are 4 videos in total, broken down into the4-day program. The schedule will guide you through each days lectures. Please note Q&Awas recorded during the live course and is not available for participation in this format.

Once you have watched ALL 4 videos/days, you can complete the instructions below in order to claim credit (both CME credit and ABIM MOC points).

Course Evaluation and Claiming Credit In order to claim credit, you will need to complete an attestation and a post-course evaluation.

• Before you are able to claim credit, you will need to complete the Attestation, which isavailable under ‘Tests’. Click on the ‘Post-test’ button, adjacent to the day 4 media button,and complete the form. Once you have successfully completed the Attestation form,select the ‘CME Account’ button at the bottom of the pop-up window to be re-directedto the My CME resources.

• Next, select the ‘Complete Evaluation’ button next to 2020 Hematology and MedicalOncology Board Review: Contemporary Practice (ONLINE) in order to complete thepost-course evaluation and claim credit.

• To access the ABIM MOC post-test, select ‘Yes’ when prompted to take theABIM MOC post-test. The post-test must be completed in one sitting and youwill have up to 10 chances to pass the test. A passing score of 80% is required toclaim ABIM MOC Points. Once you complete the post-test, you will need to goback and complete a course evaluation in order to download a CME certificate.

• If you only wish to claim CME credit, select ‘No’ when prompted to take theABIM MOC post-test and you will continue to through to the post-courseevaluation.

• Once the post-course evaluation is complete, both your CME and ABIM MOCcertificate(s) will be available to download under ‘Evaluations & Certificates’.

Please note that a course evaluation and the ABIM MOC post-test must be completed by November 1, 2020 in order to claim credit. The course content (videos and the syllabus) will remain available to attendees after November 1, 2020.

Access GuideFOR REGISTERED ATTENDEES